Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 37 Carcinoma, Non-Small-Cell Lung 30 Carcinoma, Hepatocellular 23 Esophageal Squamous Cell Carcinoma 22 Triple Negative Breast Neoplasms 19 Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Advanced Solid Tumor 17 Melanoma 15 Stomach Neoplasms 14 Uterine Cervical Neoplasms 12 Colorectal Neoplasms 12 Small Cell Lung Carcinoma 11 Neoplasms 10 Carcinoma, Transitional Cell 10 Recurrence 9 Carcinoma, Renal Cell 9 Solid Tumor 7 Sarcoma 7 Neoplasm Metastasis 7 Liver Neoplasms 7 Head and Neck Neoplasms 7 Esophageal Neoplasms 6 Rectal Neoplasms 5 Advanced Solid Tumors 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Cholangiocarcinoma 4

Interventions

pembrolizumab 2 toripalimab 1 sintilimab 1 pemigatinib 1 osimertinib 1 durvalumab 1 Vinorelbine 1 Platinum Compounds 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04144608 2024-08-09

TOGATHER

Hunan Province Tumor Hospital

Phase 2 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡